Head of Investor Relations
Tonix Pharmaceuticals Holding Corp. (TNXP)Equibles does not estimate personal net worth.
Get an email with a short summary when Tonix Pharmaceuticals Holding Corp. publishes a filing, an earnings call transcript or a press release.
Get TNXP alertsDeborah Elson is recorded as Head of Investor Relations at Tonix Pharmaceuticals Holding Corp. (TNXP). Deborah Elson has spoken on 1 earnings call across 1 company, most recently for Tonix Pharmaceuticals Holding Corp. on August 10, 2026. Tonix Pharmaceuticals Holding Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tonix Pharmaceuticals Holding Corp. includes Seth Lederman (CEO and Board Member), Bradley Saenger (CFO), Siobhan Fogarty (CTO) and 7 others.
“We appreciate you joining us today to discuss Tonics Pharmaceuticals' second quarter 2026 financial results and operational highlights.”
Head of Investor Relations
Transcript header (unverified)
Biotechnology · Healthcare
Head of Investor Relations
